Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Novel interdisciplinary intervention, GAIN, versus enhanced usual care to reduce high levels of post-concussion symptoms in adolescents and young adults 2 to 6 months post-injury: a randomised trial [with consumer summary]
Thastum MM, Rask CU, Naess-Schmidt ET, Tuborgh A, Jensen JS, Svendsen SW, Nielsen JF, Schroder A
EClinicalMedicine 2019 Dec;17:100214
clinical trial
8/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

BACKGROUND: Evidence for effective interventions to prevent long-term sequelae after concussion is sparse. This study aimed to test the efficacy of Get going After concussIoN (GAIN), an interdisciplinary, individually-tailored intervention of 8 weeks duration based on gradual return to activities and principles from cognitive behavioural therapy. METHOD(S): We conducted an open-label, parallel-group randomised trial in a hospital setting in Central Denmark Region. Participants were 15 to 30-year-old patients with high levels of post-concussion symptoms (PCS) 2 to 6 months post-concussion (ie, a score >= 20 on the Rivermead Post-concussion Symptoms Questionnaire (RPQ)). They were randomly assigned (1:1) to either enhanced usual care (EUC) or GAIN+EUC. Masking of participants and therapists was not possible. The primary outcome was change in RPQ-score from baseline to 3-month FU. All analyses were done on an intention-to-treat basis using linear mixed-effects models. This trial is registered with ClinicalTrials.gov number NCT02337101. FINDING(S): Between March 1, 2015, and September 1, 2017, we included 112 patients. Patients allocated to GAIN+EUC (n = 57) reported a significantly larger reduction of PCS than patients allocated to EUC (n = 55) with a mean adjusted difference in improvement of 7.6 points (95% confidence interval (CI) 2.0 to 13.1, p = 0.008), Cohen's d = 0.5 (95% CI 0.1 to 0.9). Number needed to treat for prevention of one additional patient with RPQ >= 20 at 3-month FU was 3.6 (95%CI 2.2 to 11.3). No adverse events were observed. INTERPRETATION(S): Compared with EUC, GAIN+EUC was associated with a larger reduction of post-concussion symptoms at 3-month FU. FUNDING(S): Central Denmark Region and the foundation "Public Health in Central Denmark Region -- a collaboration between municipalities and the region".

Full text (sometimes free) may be available at these link(s):      help